Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Circulatory

  • 1
    News

    Beware of polypharmacy in patients taking warfarin

    March 20, 2018

    SAN DIEGO – The incidence of polypharmacy among patients on warfarin therapy appears to peak at age 75.

  • 1
    News

    Ticagrelor noninferior to clopidogrel in terms of major bleeds in STEMI

    March 11, 2018

    New STEMI data answer some but not all questions.

  • 1
    Video

    Post-ACS death lowered in ODYSSEY Outcomes 

    March 10, 2018

    ORLANDO – Mortality and major adverse cardiovascular events were cut 15%, but that’s not all.

  • 1
    Article

    A simplified risk prediction model for patients presenting with acute pulmonary embolism

    February 21, 2018

    Is there a simplified risk prediction model to identify those with low risk pulmonary embolism (PE) who can be treated as outpatients?

  • 1
    Article

    Anticoagulation use in new-onset secondary atrial fibrillation

    February 16, 2018

    Is anticoagulant use in patients with new-­onset atrial fibrillation secondary to acute coronary syndrome, acute pulmonary disease, or sepsis associated with a reduction in ischemic stroke or an increase in bleeding risk?

  • 1
    Article

    Rivaroxaban versus warfarin in mild acute ischemic stroke secondary to atrial fibrillation

    February 12, 2018

    Clinical question: Is rivaroxaban as effective and safe as warfarin immediately following minor acute ischemic stroke from atrial fibrillation?

  • 1
    News

    Controversy surrounds calf vein thrombosis treatment

    January 30, 2018

    CHICAGO – Anticoagulation, filter, or surveillance? Large retrospective study provides answers.

  • 1
    News

    Triple therapy in question

    January 16, 2018

    Clinical question: In patients with nonvalvular atrial fibrillation undergoing percutaneous coronary intervention (PCI), is dabigatran plus a P2Y12 inhibitor safer than, and as efficacious as, triple therapy with warfarin?

  • 1
    News

    Rivaroxaban lowers cardiovascular risk but increases bleeding risk

    January 16, 2018

    Is rivaroxaban alone or in combination with aspirin more effective than is aspirin alone in preventing cardiovascular events in patients with stable atherosclerotic disease?

  • News

    Idarucizumab reverses anticoagulation effects of dabigatran

    December 14, 2017

    Can idarucizumab reverse anticoagulation effects of dabigatran in a timely manner for urgent surgery or in the event of bleeding?

Previous1 … 17 18 19 20 21 … 25Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences